AVENZO
Avenzo manufactures and distributes a broad range of electronics products, including headphones and speakers.
AVENZO
Industry:
Consumer Electronics Electronics Manufacturing
Founded:
2012-01-01
Address:
Las Rozas De Madrid, Madrid, Spain
Country:
Spain
Website Url:
http://www.avenzo.es
Total Employee:
1+
Status:
Active
Contact:
+34 915 123 076
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Google Maps CrUX Dataset Google Maps API CrUX Top 5m
Similar Organizations
Ascendo Immersive Audio
Ascendo Immersive Audio design manufactures and distributes a variety of AIA technology-equipped subwoofers, speakers, and amplifiers.
Casper
Casper manufactures and delivers a broad range of consumer electronics ranging from phones, tablets, laptops to gaming desktop computers.
Intos Electronic
Intos Electronic is a manufacturer and distributor of electronic accessories, smartphones, and tablets.
One For All
One For All is a manufacturer and supplier of electronics products, digital audio, and video accessories.
RDP Electronics
RDP Electronics manufactures and distributes a wide range of transducers, instrumentation, amplifiers and various electrical applications.
Stevenage Circuits
Stevenage Circuits designs and manufactures a wide range of electronic products including lasers, rigid, microwave and multi-layer PCBs.
Official Site Inspections
http://www.avenzo.es Semrush global rank: 3.36 M Semrush visits lastest month: 4.14 K
- Host name: dns13583.phdns18.es
- IP address: 154.56.135.83
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avenzo"
Avenzo Therapeutics Company Profile 2024: Valuation, …
Avenzo Therapeutics General Information Description. Operator of a clinical-stage oncology platform intended to develop novel treatments for underserved …See details»
Avenzo Therapeutics - Crunchbase Company Profile
Avenzo Therapeutics successfully closed a $150 million oversubscribed Series A-1 financing round to advance its emerging oncology pipeline. The company …See details»
Org Chart Avenzo Therapeutics - The Official Board
The organizational chart of Avenzo Therapeutics displays its 26 main executives including Athena Countouriotis, Paolo Tombesi and Mohammad Hirmand. Toggle navigation The Official Board. …See details»
Avenzo Therapeutics
Keep up with Avenzo on our mission to develop the next generation of oncology therapies for patients. Learn More. Contact Us. Are you interested in joining our team, learning more or …See details»
Avenzo Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
SAN DIEGO--( BUSINESS WIRE )-- Avenzo Therapeutics, Inc . (“Avenzo”), a clinical-stage biotechnology company developing the next generation of oncology therapeutics, today …See details»
Avenzo Therapeutics - Company Profile - Tracxn
Oct 11, 2024 Avenzo Therapeutics - Developer of therapeutics for the treatment of cancer. Raised a total funding of $31.5M over 1 round. Avenzo Therapeutics has 2860 competitors.See details»
Avenzo Therapeutics - Updates, News, Events, Signals & Triggers
Avenzo Therapeutics successfully closed a $150 million oversubscribed Series A-1 financing round to advance its emerging oncology pipeline. The company also received a $150 million …See details»
Avenzo Therapeutics - Overview, News & Similar companies
Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients. The com pany's lead drug candidate, AVZO …See details»
Avenzo Global Tech - Overview, News & Similar companies
Who is Avenzo Global Tech. Avenzo Global Tech Sl is a company that operates in the Information Technology and Services industry. It employs 11-20 people and has $5M-$10M of r evenue. …See details»
Avenzo Therapeutics Company Profile - Office Locations ... - Craft
Avenzo Therapeutics is a clinical-stage biotechnology company that specializes in developing oncology therapies. It offers AVZO-021, a cyclin-dependent kinase 2 (CDK2) inhibitor for …See details»
Board of Directors: Athena Countouriotis | BioMarin
Countouriotis is co-founder, President, Chief Executive Officer and Chairperson of Avenzo Therapeutics, Inc., a private biotechnology company. Prior to that, she served as President …See details»
Turning Point team quietly reforms at Avenzo, raises $196M
May 25, 2023 In the wake of Turning Point’s $4.1 billion acquisition by BMS, a group of the biotech’s former employees has quietly formed new oncology start-up Avenzo and drawn the …See details»
Avenzo Therapeutics Honored by Goldman Sachs for …
Oct 16, 2024 Athena Countouriotis, M.D., CEO Among the Most Exceptional Entrepreneurs at 2024 Builders and Innovators Summit. San Diego, Calif. – October 16, 2024 – Avenzo …See details»
Avenzo Therapeutics Announces Appointment of Patrick …
Nov 20, 2024 Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation oncology therapies for patients. The company’s lead drug …See details»
Ex-Turning Point leaders license first oncology assets for new …
January 4, 2024 Mary Canady News, Syndication Comments Off on Ex-Turning Point leaders license first oncology assets for new startup Avenzo Athena Countouriotis and her former …See details»
Avenzo Therapeutics Honored by Goldman Sachs for …
Oct 16, 2024 Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients. The company’s lead drug …See details»
Avenzo Therapeutics secures $150m to progress oncology pipeline
Mar 27, 2024 Avenzo has appointed Sofinnova Investments’ private equity executive partner Jakob Dupont to its board of directors. Avenzo co-founder, president and CEO Athena …See details»
Avenzo Therapeutics Announces Appointment of Garry Nicholson …
Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients. The company’s lead drug candidate, AVZO-021, …See details»
Avenzo - nea.com
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation of small-molecule and ADC oncology therapies for patients. Sectors. Life Sciences. …See details»